BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ringman JM, Sachs MC, Zhou Y, Monsell SE, Saver JL, Vinters HV. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease. JAMA Neurol 2014;71:878-83. [PMID: 24797962 DOI: 10.1001/jamaneurol.2014.681] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Piccarducci R, Caselli MC, Zappelli E, Ulivi L, Daniele S, Siciliano G, Ceravolo R, Mancuso M, Baldacci F, Martini C. The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy. J Alzheimers Dis 2022. [PMID: 35964181 DOI: 10.3233/JAD-220216] [Reference Citation Analysis]
2 Ma Y, Sajeev G, VanderWeele TJ, Viswanathan A, Sigurdsson S, Eiriksdottir G, Aspelund T, Betensky RA, Grodstein F, Hofman A, Gudnason V, Launer L, Blacker D. APOE ε4 and late-life cognition: mediation by structural brain imaging markers. Eur J Epidemiol 2022. [PMID: 35471691 DOI: 10.1007/s10654-022-00864-7] [Reference Citation Analysis]
3 Nguyen ML, Huie EZ, Whitmer RA, George KM, Dugger BN. Neuropathology Studies of Dementia in US Persons other than Non-Hispanic Whites. Free Neuropathol 2022;3. [PMID: 35425946 DOI: 10.17879/freeneuropathology-2022-3795] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Lozano S, Padilla V, Avila ML, Gil M, Maestre G, Wang K, Xu C. APOE Gene Associated with Cholesterol-Related Traits in the Hispanic Population. Genes (Basel) 2021;12:1768. [PMID: 34828374 DOI: 10.3390/genes12111768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Koudriavtseva T, Lorenzano S, Anelli V, Sergi D, Stefanile A, Di Domenico EG, Maschio M, Galiè E, Piantadosi C. Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer. Front Oncol 2021;11:669753. [PMID: 34386418 DOI: 10.3389/fonc.2021.669753] [Reference Citation Analysis]
6 Jellinger KA. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases. J Neural Transm (Vienna) 2021;128:687-99. [PMID: 33928445 DOI: 10.1007/s00702-021-02345-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ringman JM, Joe E, Sheikh-Bahaei N, Miller C, Vinters HV, Guzman S, Chui HC. Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease. Alzheimer Dis Assoc Disord 2021;35:265-8. [PMID: 33480610 DOI: 10.1097/WAD.0000000000000432] [Reference Citation Analysis]
8 Kapoor A, Nation DA. Role of Notch signaling in neurovascular aging and Alzheimer's disease. Semin Cell Dev Biol 2021;116:90-7. [PMID: 33384205 DOI: 10.1016/j.semcdb.2020.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Emrani S, Arain HA, DeMarshall C, Nuriel T. APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review. Alzheimers Res Ther 2020;12:141. [PMID: 33148345 DOI: 10.1186/s13195-020-00712-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
10 Wardlaw JM, Doubal F, Brown R, Backhouse E, Woodhouse L, Bath P, Quinn TJ, Robinson T, Markus HS, McManus R, O'Brien JT, Werring DJ, Sprigg N, Parry-Jones A, Touyz RM, Williams S, Mah YH, Emsley H; R4VaD Investigators. Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: Protocol. Eur Stroke J 2021;6:89-101. [PMID: 33817339 DOI: 10.1177/2396987320953312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Hansen D, Ling H, Lashley T, Foley JA, Strand C, Eid TM, Holton JL, Warner TT. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia. Neuropathol Appl Neurobiol 2021;47:143-56. [PMID: 32720329 DOI: 10.1111/nan.12648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
12 Blanchard JW, Bula M, Davila-Velderrain J, Akay LA, Zhu L, Frank A, Victor MB, Bonner JM, Mathys H, Lin YT, Ko T, Bennett DA, Cam HP, Kellis M, Tsai LH. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med 2020;26:952-63. [PMID: 32514169 DOI: 10.1038/s41591-020-0886-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 73] [Article Influence: 25.0] [Reference Citation Analysis]
13 Tortajada-Soler M, Sánchez-Valdeón L, Blanco-Nistal M, Benítez-Andrades JA, Liébana-Presa C, Bayón-Darkistade E. Prevalence of Comorbidities in Individuals Diagnosed and Undiagnosed with Alzheimer's Disease in León, Spain and a Proposal for Contingency Procedures to Follow in the Case of Emergencies Involving People with Alzheimer's Disease. Int J Environ Res Public Health 2020;17:E3398. [PMID: 32414124 DOI: 10.3390/ijerph17103398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Malek-Ahmadi M, Chen K, Perez SE, Mufson EJ. Cerebral Amyloid Angiopathy and Neuritic Plaque Pathology Correlate with Cognitive Decline in Elderly Non-Demented Individuals. J Alzheimers Dis 2019;67:411-22. [PMID: 30594928 DOI: 10.3233/JAD-180765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
15 van Veluw SJ, Scherlek AA, Freeze WM, Ter Telgte A, van der Kouwe AJ, Bacskai BJ, Frosch MP, Greenberg SM. Different microvascular alterations underlie microbleeds and microinfarcts. Ann Neurol 2019;86:279-92. [PMID: 31152566 DOI: 10.1002/ana.25512] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
16 Chernick D, Ortiz-Valle S, Jeong A, Qu W, Li L. Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier. Neurosci Lett 2019;708:134306. [PMID: 31181302 DOI: 10.1016/j.neulet.2019.134306] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
17 Dzietko M, Schulz S, Preuss M, Haertel C, Stein A, Felderhoff-Mueser U, Goepel W. Apolipoprotein E gene polymorphisms and intraventricular haemorrhage in infants born preterm: a large prospective multicentre cohort study. Dev Med Child Neurol 2019;61:337-42. [PMID: 30084487 DOI: 10.1111/dmcn.13987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Kim SJ, Seo Y, Kim HJ, Na DL, Seo SW, Kim Y, Suh YL. Pathologically Confirmed Cerebral Amyloid Angiopathy with No Radiological Sign in a Patient with Early Onset Alzheimer's Disease. Yonsei Med J 2018;59:801-5. [PMID: 29978619 DOI: 10.3349/ymj.2018.59.6.801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Schrag M, Kirshner H. Neuropsychological Effects of Cerebral Amyloid Angiopathy. Curr Neurol Neurosci Rep 2016;16:76. [PMID: 27357378 DOI: 10.1007/s11910-016-0674-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
20 van Veluw SJ, Shih AY, Smith EE, Chen C, Schneider JA, Wardlaw JM, Greenberg SM, Biessels GJ. Detection, risk factors, and functional consequences of cerebral microinfarcts. Lancet Neurol 2017;16:730-40. [PMID: 28716371 DOI: 10.1016/S1474-4422(17)30196-5] [Cited by in Crossref: 125] [Cited by in F6Publishing: 69] [Article Influence: 25.0] [Reference Citation Analysis]
21 Wiesmann M, Zerbi V, Jansen D, Lütjohann D, Veltien A, Heerschap A, Kiliaan AJ. Hypertension, cerebrovascular impairment, and cognitive decline in aged AβPP/PS1 mice. Theranostics 2017;7:1277-89. [PMID: 28435465 DOI: 10.7150/thno.18509] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
22 Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study. Lancet Neurol 2017;16:66-75. [PMID: 27866858 DOI: 10.1016/S1474-4422(16)30328-3] [Cited by in Crossref: 171] [Cited by in F6Publishing: 174] [Article Influence: 28.5] [Reference Citation Analysis]
23 Bojar I, Gujski M, Pinkas J, Raczkiewicz D, Owoc A, Humeniuk E. Interaction between C-reactive protein and cognitive functions according to APOE gene polymorphism in post-menopausal women. Arch Med Sci 2016;12:1247-55. [PMID: 27904515 DOI: 10.5114/aoms.2016.62868] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
24 Sepehry AA, Rauscher A, Hsiung GY, Lang DJ. Microbleeds in Alzheimer's Disease: A Neuropsychological Overview and Meta-Analysis. Can J Neurol Sci 2016;43:753-9. [PMID: 27640605 DOI: 10.1017/cjn.2016.296] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
25 Roshchupkin GV, Adams HH, van der Lee SJ, Vernooij MW, van Duijn CM, Uitterlinden AG, van der Lugt A, Hofman A, Niessen WJ, Ikram MA. Fine-mapping the effects of Alzheimer's disease risk loci on brain morphology. Neurobiol Aging 2016;48:204-11. [PMID: 27718423 DOI: 10.1016/j.neurobiolaging.2016.08.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
26 Shinohara M, Murray ME, Frank RD, Shinohara M, DeTure M, Yamazaki Y, Tachibana M, Atagi Y, Davis MD, Liu CC, Zhao N, Painter MM, Petersen RC, Fryer JD, Crook JE, Dickson DW, Bu G, Kanekiyo T. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease. Acta Neuropathol 2016;132:225-34. [PMID: 27179972 DOI: 10.1007/s00401-016-1580-y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
27 Tai LM, Thomas R, Marottoli FM, Koster KP, Kanekiyo T, Morris AW, Bu G. The role of APOE in cerebrovascular dysfunction. Acta Neuropathol 2016;131:709-23. [PMID: 26884068 DOI: 10.1007/s00401-016-1547-z] [Cited by in Crossref: 107] [Cited by in F6Publishing: 96] [Article Influence: 17.8] [Reference Citation Analysis]
28 Zha Z, Song J, Choi SR, Wu Z, Ploessl K, Smith M, Kung H. 68 Ga-Bivalent Polypegylated Styrylpyridine Conjugates for Imaging Aβ Plaques in Cerebral Amyloid Angiopathy. Bioconjugate Chem 2016;27:1314-23. [DOI: 10.1021/acs.bioconjchem.6b00127] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
29 Ringman JM, Monsell S, Ng DW, Zhou Y, Nguyen A, Coppola G, Van Berlo V, Mendez MF, Tung S, Weintraub S, Mesulam MM, Bigio EH, Gitelman DR, Fisher-Hubbard AO, Albin RL, Vinters HV. Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database. J Neuropathol Exp Neurol 2016;75:284-90. [PMID: 26888304 DOI: 10.1093/jnen/nlv028] [Cited by in Crossref: 46] [Cited by in F6Publishing: 54] [Article Influence: 7.7] [Reference Citation Analysis]
30 Rusted J, Carare RO. Are the effects of APOE ϵ4 on cognitive function in nonclinical populations age- and gender-dependent? Neurodegener Dis Manag 2015;5:37-48. [PMID: 25711453 DOI: 10.2217/nmt.14.43] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
31 Wiesmann M, Roelofs M, van der Lugt R, Heerschap A, Kiliaan AJ, Claassen JA. Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease. J Cereb Blood Flow Metab 2017;37:2396-413. [PMID: 27596834 DOI: 10.1177/0271678X16667364] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
32 Shams S, Wahlund LO. Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field. Biomark Med 2016;10:9-18. [PMID: 26641942 DOI: 10.2217/bmm.15.101] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
33 Brenowitz WD, Nelson PT, Besser LM, Heller KB, Kukull WA. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes. Neurobiol Aging 2015;36:2702-8. [PMID: 26239176 DOI: 10.1016/j.neurobiolaging.2015.06.028] [Cited by in Crossref: 57] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
34 Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, Ghetti B, Morris JC; Dominantly Inherited Alzheimer Network. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Curr Neurol Neurosci Rep 2014;14:499. [PMID: 25217249 DOI: 10.1007/s11910-014-0499-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
35 Sweeney MD, Sagare AP, Zlokovic BV. Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease. J Cereb Blood Flow Metab 2015;35:1055-68. [PMID: 25899298 DOI: 10.1038/jcbfm.2015.76] [Cited by in Crossref: 60] [Cited by in F6Publishing: 70] [Article Influence: 8.6] [Reference Citation Analysis]
36 Charidimou A. Elderly and forgetful with transient neurological spells: A story of two amyloids? Journal of the Neurological Sciences 2015;351:1-2. [DOI: 10.1016/j.jns.2015.02.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]